These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30996692)

  • 1. Surveillance of laboratory exposures to human pathogens and toxins: Canada 2017.
    Pomerleau-Normandin D; Heisz M; Tanguay F
    Can Commun Dis Rep; 2018 Nov; 44(11):297-304. PubMed ID: 30996692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of laboratory exposures to human pathogens and toxins: Canada 2016.
    Bienek A; Heisz M; Su M
    Can Commun Dis Rep; 2017 Nov; 43(11):228-235. PubMed ID: 29770052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of laboratory exposures to human pathogens and toxins: Canada 2018.
    Choucrallah D; Sarmiento L; Ettles S; Tanguay F; Heisz M; Falardeau E
    Can Commun Dis Rep; 2019 Sep; 45(9):244-251. PubMed ID: 31650987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2021.
    Thompson ER; El Jaouhari M; Eltayeb N; Abalos C; Striha M; Edjoc R; Ayoo C; Bonti-Ankomah S
    Can Commun Dis Rep; 2022 Oct; 48(10):484-491. PubMed ID: 38125397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2022.
    Abalos C; Gauthier A; Davis A; Ellis C; Balbontin N; Kapur A; Bonti-Ankomah S
    Can Commun Dis Rep; 2023 Sep; 49(9):398-405. PubMed ID: 38463906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of laboratory exposures to human pathogens and toxins, Canada 2020.
    Atchessi N; Striha M; Edjoc R; Thompson E; El Jaouhari M; Heisz M
    Can Commun Dis Rep; 2021 Oct; 47(10):422-429. PubMed ID: 34737674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian laboratory incidents with human pathogens and toxins: An overview of reports, 2016-2022.
    Balbontin N; Gauthier A; Abalos C; Davis AN; Lister M
    Can Commun Dis Rep; 2024 May; 50(5):144-152. PubMed ID: 38835500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate analyses of risk factors associated with laboratory exposure incidents.
    El Jaouhari M; Atchessi N; Edjoc R; Striha M; Bonti-Ankomah S
    Can Commun Dis Rep; 2022 Jul; 48(7-8):350-355. PubMed ID: 37416113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misidentification of Risk Group 3/Security Sensitive Biological Agents by MALDI-TOF MS in Canada: November 2015-October 2017.
    Pomerleau-Normandin D; Heisz M; Su M
    Can Commun Dis Rep; 2018 May; 44(5):110-115. PubMed ID: 31007621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory-acquired infections in Canada from 2016 to 2021.
    El Jaouhari M; Striha M; Edjoc R; Bonti-Ankomah S
    Can Commun Dis Rep; 2022 Jul; 48(7-8):303-307. PubMed ID: 37334256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melioidosis Cases and Selected Reports of Occupational Exposures to Burkholderia pseudomallei--United States, 2008-2013.
    Benoit TJ; Blaney DD; Gee JE; Elrod MG; Hoffmaster AR; Doker TJ; Bower WA; Walke HT;
    MMWR Surveill Summ; 2015 Jul; 64(5):1-9. PubMed ID: 26135734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory oversight of human pathogens and toxins in Canada.
    Labrie C; Lecordier S
    Can Commun Dis Rep; 2015 Dec; 41(Suppl 6):14-18. PubMed ID: 29769973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Toxic Substances Incidents Program - Nine States, 2010-2014.
    Melnikova N; Wu J; Ruiz P; Orr MF
    MMWR Surveill Summ; 2020 Mar; 69(2):1-10. PubMed ID: 32191685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hidden face of academic researches on classified highly pathogenic microorganisms.
    Devaux CA
    Infect Genet Evol; 2015 Jan; 29():26-34. PubMed ID: 25445654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute chemical incidents surveillance—Hazardous Substances Emergency Events Surveillance, nine states, 1999-2008.
    Orr MF; Wu J; Sloop SL;
    MMWR Suppl; 2015 Apr; 64(2):1-9. PubMed ID: 25856532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year prospective study to improve the management of blood-exposure incidents.
    van Wijk PT; Pelk-Jongen M; Wijkmans C; Voss A; Schneeberger PM
    Infect Control Hosp Epidemiol; 2008 Sep; 29(9):871-7. PubMed ID: 18724826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of a standardized incident reporting system in the perioperative setting: a single center experience on 2,563 'near-misses' and adverse events.
    Heideveld-Chevalking AJ; Calsbeek H; Damen J; Gooszen H; Wolff AP
    Patient Saf Surg; 2014; 8(1):46. PubMed ID: 25632301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory-acquired infection in clinical laboratories and the incidence rate after Brucella exposure risk events: a systematic review and meta-analysis.
    Wang M; Sun W; Zhou C; Wang S; Shi Q; Lin J; Mi H; Hu B; Pan J; Gao X
    J Hosp Infect; 2024 Oct; ():. PubMed ID: 39427772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of interventions triggered by hepatitis A infected food-handlers in Canada.
    Tricco AC; Pham B; Duval B; De Serres G; Gilca V; Vrbova L; Anonychuk A; Krahn M; Moher D
    BMC Health Serv Res; 2006 Dec; 6():157. PubMed ID: 17156461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between hospital- and community-acquired blood exposure incidents revealed by a regional expert counseling center.
    van Wijk PT; Pelk-Jongen M; de Boer E; Voss A; Wijkmans C; Schneeberger PM
    Infection; 2006 Feb; 34(1):17-21. PubMed ID: 16501897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.